Put companies on watchlist
Mynaric
ISIN: US62857X1019
WKN: A3C7GA
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Mynaric · ISIN: US62857X1019 · Business Wire (ID: 20241031779512)
31 October 2024 06:57PM

MYNA Investors Have Opportunity to Lead Mynaric AG Securities Fraud Lawsuit with the Schall Law Firm


MYNA Investors Have Opportunity to Lead Mynaric AG Securities Fraud Lawsuit with the Schall Law Firm

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Mynaric AG (“Mynaric” or “the Company”) (NASDAQ: MYNA) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between June 20, 2024 and October 7, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before December 30, 2024.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Mynaric’s low production yields and component shortages caused production delays in its CONDOR Mk3 product. The Company’s production problems were likely to negatively impact its revenue growth and financial performance. The Company’s financial prospects were overstated. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about Mynaric, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

Contact

The Schall Law Firm
Brian Schall, Esq.
www.schallfirm.com
Office: 310-301-3335
info@schallfirm.com

Visual performance / price development - Mynaric
Smart analysis and research tools can be found here.
This publication was provided by our content partner Business Wire
BusinessWire
via BusinessWire - Newsfeed
BusinessWire ©2024
BusinessWire
Contact:
101 California Street, 20th Floor San Francisco, CA, 94111 United States
+1.415.986.4422